FMR1 and fragile X syndrome: Given the significant impact fragile X syndrome has on families, together with the lack of curative treatment, the FMR1 premutation is considered a prime candidate for population‐based screening programs (preconception/prenatal/newborn) internationally (Hill et al., 2010).